Health Library Anakinra for Rheumatoid ArthritisFrom Healthwise

Anakinra is administered by a shot under the skin (subcutaneous injection), usually once a day.

Anakinra limits the action of an inflammatory substance known as interleukin (IL-1) that attaches to the joint surface and promotes inflammation. Anakinra is a disease-modifying antirheumatic drug (DMARD), which means it slows the progression of rheumatoid arthritis. DMARDs are also called immunosuppressive drugs or slow-acting antirheumatic drugs (SAARDs).

Anakinra has been approved for use in adults with moderate to severe rheumatoid arthritis if at least one other DMARD is not effective.

Anakinra shows moderately good results in improving symptoms of rheumatoid arthritis when taken alone and when taken in combination with methotrexate.¹

Side effects of anakinra may include:

• Allergic reaction.
• Nausea.
• Diarrhea.
• Headache.
• Redness, bruising, pain, or swelling at the injection site.
• Rare cases of lowered white blood cell counts (possibly due to simultaneous treatment with methotrexate).

Rare cases of serious infections have been reported during treatment with anakinra. Because anakinra decreases the action of your body's natural immune system, fever and chills are considered serious side effects that should be reported to your health professional immediately. If you develop any infection, you should contact your doctor, who may advise that you temporarily discontinue use of anakinra.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

Talk to your health professional before taking anakinra if you are breast-feeding, pregnant, or thinking about becoming pregnant.

Anakinra can be self-administered once you have received training and instructions from your health professional.

Anakinra is a relatively new medicine, so its long-term side effects are not yet known.

Complete the new medication information form (PDF) (What is a PDF document?) to help you understand this medication.

Citations

1. Drugs for rheumatoid arthritis (2005). Treatment Guidelines From the Medical Letter, 3(40): 83-90.

Author:	Shannon Erstad, MBA/MPH	Last Updated: August 18, 2008
Medical Review:	Anne C. Poinier, MD - Internal Medicine Stanford M. Shoor, MD - Rheumatology
© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.